Markus Helfer
Impact in
- Virology top 10%
- HIV Research and Treatment
- Pharmacology top 10%
Papers in
- Virology 7
- HIV Research and Treatment 6
-
- HIV/AIDS drug development and treatment 4
- HIV/AIDS Research and Interventions 2
- Viral Infections and Outbreaks Research 2
- Co-authors
- Ruth Brack‐Werner (10 shared papers)Martha Schneider (4 shared papers)Michael Schindler (3 shared papers)Herwig Koppensteiner (2 shared papers)Stephanie Rebensburg (2 shared papers)Philippe Schmitt‐Kopplin (3 shared papers)Stephan Kremb (4 shared papers)Josef Eberle (1 shared paper)
- Journals
- PLoS ONE (3 papers)Scientific Reports (1 paper)AIDS (1 paper)Cells (1 paper)Molecular Therapy — Nucleic Acids (1 paper)
- Partner nations
- GermanySlovakiaUnited States
In The Last Decade
Markus Helfer
12 papers receiving 381 citations
Peers
Comparison fields: 5 of 82
- Virology 77
- Pharmacology 45
- Infectious Diseases 86
- Complementary and alternative medicine 38
- Biotechnology 30
Countries citing papers authored by Markus Helfer
This map shows the geographic impact of Markus Helfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Helfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Helfer more than expected).
Fields of papers citing papers by Markus Helfer
This network shows the impact of papers produced by Markus Helfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Helfer. The network helps show where Markus Helfer may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Helfer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 80 | |
| 2 | 2016 | 73 | |
| 3 | 2015 | 52 | |
| 4 | 2010 | 35 | |
| 5 | 2016 | 32 | |
| 6 | 2009 | 30 | |
| 7 | 2016 | 27 | |
| 8 | 2015 | 18 | |
| 9 | 2020 | 16 | |
| 10 | 2014 | 12 | |
| 11 | 2019 | 11 | |
| 12 | 2010 | 8 |
About Markus Helfer
Markus Helfer is a scholar working on Virology, Infectious Diseases, Molecular Biology, Organic Chemistry and Pharmacology, having authored 12 papers that have together received 394 indexed citations. Recurring topics across this work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (4 papers), HIV/AIDS Research and Interventions (2 papers), Viral Infections and Outbreaks Research (2 papers), Marine and coastal plant biology (1 paper), Chemical synthesis and alkaloids (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper) and Synthesis and Biological Activity (1 paper). The work is most often cited by research in Virology (77 citations), Pharmacology (45 citations), Infectious Diseases (86 citations), Complementary and alternative medicine (38 citations) and Biotechnology (30 citations). Markus Helfer has collaborated with scholars based in Germany, Slovakia and United States. Frequent co-authors include Ruth Brack‐Werner, Martha Schneider, Michael Schindler, Herwig Koppensteiner, Stephanie Rebensburg, Philippe Schmitt‐Kopplin, Stephan Kremb, Josef Eberle, Lutz Gürtler and Sara Forcisi. Their work appears in journals such as PLoS ONE, Scientific Reports, AIDS, Cells and Molecular Therapy — Nucleic Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.